Riddhi Siddhi Gluco Biols Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 286.34 million compared to INR 1,040.03 million a year ago. Revenue was INR 459.89 million compared to INR 1,193.96 million a year ago. Net income was INR 43.77 million compared to net loss of INR 76.84 million a year ago. Basic earnings per share from continuing operations was INR 6.14 compared to basic loss per share from continuing operations of INR 10.78 a year ago. Diluted earnings per share from continuing operations was INR 6.14 compared to diluted loss per share from continuing operations of INR 10.78 a year ago.
For the nine months, sales was INR 1,567.62 million compared to INR 4,763.08 million a year ago. Revenue was INR 2,089.12 million compared to INR 5,240.58 million a year ago. Net income was INR 111.84 million compared to INR 167.79 million a year ago. Basic earnings per share from continuing operations was INR 15.69 compared to INR 23.53 a year ago. Diluted earnings per share from continuing operations was INR 15.69 compared to INR 23.53 a year ago.